The inhibition of HIV-1 activity by crude mucus and purified mucin (mucous glycoproteins) from saliva, breast milk and the cervical tract of normal subjects, HIV positive individuals and patients with HIV-AIDS

Includes bibliographical references (leaves 140-161). === Human saliva, breast milk and cervical secretions contain several non-immunological components including mucins (mucous glycoproteins), which protect the gastrointesinal and female reproductive tracts and breast fed infants from bacterial, vi...

Full description

Bibliographic Details
Main Author: Habte, Habtom Haileselassie
Other Authors: Mall, Anwar Suleman
Format: Doctoral Thesis
Language:English
Published: University of Cape Town 2014
Subjects:
Online Access:http://hdl.handle.net/11427/10629
id ndltd-netd.ac.za-oai-union.ndltd.org-uct-oai-localhost-11427-10629
record_format oai_dc
spelling ndltd-netd.ac.za-oai-union.ndltd.org-uct-oai-localhost-11427-106292020-07-22T05:08:06Z The inhibition of HIV-1 activity by crude mucus and purified mucin (mucous glycoproteins) from saliva, breast milk and the cervical tract of normal subjects, HIV positive individuals and patients with HIV-AIDS Habte, Habtom Haileselassie Mall, Anwar Suleman Surgery Includes bibliographical references (leaves 140-161). Human saliva, breast milk and cervical secretions contain several non-immunological components including mucins (mucous glycoproteins), which protect the gastrointesinal and female reproductive tracts and breast fed infants from bacterial, viral and fungal infections. In addition to their well known function in lubrication, tissue coating and digestion, mucus and mcins have been used as pathological markers in diseases such as asthma, chronic bronchitis, cystic fibrosis, and carcinomas of the breast, lung and colon. Crude saliva is a also known to inhibit the activity of human immunodeficiency virus (HIV), the causative agent of acquired immunodeficiency syndrome (AIDS). According to the joint United Nations Programme on HIV/AIDS (UNAIDS) worldwide an estimated 38.6 million people were living with HIV in 2005 with 401 million newly infected and 2.8 million deaths. It has been reported that an estimated 24.5 million of the HIV infected people of whom 60% females live in sub-Saharan Africa with the Southern African region having the highest prevalence in Africa. Furthermore the incidence of opportunistic diseases such as TB is also reported to increase with HIV prevalence. Thus far, despite the discovery of highly active antiretroviral therapies which contain both protease and reverse transcriptase inhibitors, HIV remains as a global threat especially to the third world countries. Therefore there is a need for the development of safe compounds to reduce viral loads in infected people and to prevent the transmission of the virus from one individual to another. The search for a suitable vaccine is ongoing. 2014-12-30T19:50:01Z 2014-12-30T19:50:01Z 2007 Doctoral Thesis Doctoral PhD http://hdl.handle.net/11427/10629 eng application/pdf University of Cape Town Faculty of Health Sciences Department of Surgery
collection NDLTD
language English
format Doctoral Thesis
sources NDLTD
topic Surgery
spellingShingle Surgery
Habte, Habtom Haileselassie
The inhibition of HIV-1 activity by crude mucus and purified mucin (mucous glycoproteins) from saliva, breast milk and the cervical tract of normal subjects, HIV positive individuals and patients with HIV-AIDS
description Includes bibliographical references (leaves 140-161). === Human saliva, breast milk and cervical secretions contain several non-immunological components including mucins (mucous glycoproteins), which protect the gastrointesinal and female reproductive tracts and breast fed infants from bacterial, viral and fungal infections. In addition to their well known function in lubrication, tissue coating and digestion, mucus and mcins have been used as pathological markers in diseases such as asthma, chronic bronchitis, cystic fibrosis, and carcinomas of the breast, lung and colon. Crude saliva is a also known to inhibit the activity of human immunodeficiency virus (HIV), the causative agent of acquired immunodeficiency syndrome (AIDS). According to the joint United Nations Programme on HIV/AIDS (UNAIDS) worldwide an estimated 38.6 million people were living with HIV in 2005 with 401 million newly infected and 2.8 million deaths. It has been reported that an estimated 24.5 million of the HIV infected people of whom 60% females live in sub-Saharan Africa with the Southern African region having the highest prevalence in Africa. Furthermore the incidence of opportunistic diseases such as TB is also reported to increase with HIV prevalence. Thus far, despite the discovery of highly active antiretroviral therapies which contain both protease and reverse transcriptase inhibitors, HIV remains as a global threat especially to the third world countries. Therefore there is a need for the development of safe compounds to reduce viral loads in infected people and to prevent the transmission of the virus from one individual to another. The search for a suitable vaccine is ongoing.
author2 Mall, Anwar Suleman
author_facet Mall, Anwar Suleman
Habte, Habtom Haileselassie
author Habte, Habtom Haileselassie
author_sort Habte, Habtom Haileselassie
title The inhibition of HIV-1 activity by crude mucus and purified mucin (mucous glycoproteins) from saliva, breast milk and the cervical tract of normal subjects, HIV positive individuals and patients with HIV-AIDS
title_short The inhibition of HIV-1 activity by crude mucus and purified mucin (mucous glycoproteins) from saliva, breast milk and the cervical tract of normal subjects, HIV positive individuals and patients with HIV-AIDS
title_full The inhibition of HIV-1 activity by crude mucus and purified mucin (mucous glycoproteins) from saliva, breast milk and the cervical tract of normal subjects, HIV positive individuals and patients with HIV-AIDS
title_fullStr The inhibition of HIV-1 activity by crude mucus and purified mucin (mucous glycoproteins) from saliva, breast milk and the cervical tract of normal subjects, HIV positive individuals and patients with HIV-AIDS
title_full_unstemmed The inhibition of HIV-1 activity by crude mucus and purified mucin (mucous glycoproteins) from saliva, breast milk and the cervical tract of normal subjects, HIV positive individuals and patients with HIV-AIDS
title_sort inhibition of hiv-1 activity by crude mucus and purified mucin (mucous glycoproteins) from saliva, breast milk and the cervical tract of normal subjects, hiv positive individuals and patients with hiv-aids
publisher University of Cape Town
publishDate 2014
url http://hdl.handle.net/11427/10629
work_keys_str_mv AT habtehabtomhaileselassie theinhibitionofhiv1activitybycrudemucusandpurifiedmucinmucousglycoproteinsfromsalivabreastmilkandthecervicaltractofnormalsubjectshivpositiveindividualsandpatientswithhivaids
AT habtehabtomhaileselassie inhibitionofhiv1activitybycrudemucusandpurifiedmucinmucousglycoproteinsfromsalivabreastmilkandthecervicaltractofnormalsubjectshivpositiveindividualsandpatientswithhivaids
_version_ 1719331369380741120